Click here to see this online
 
 
 

March 14, 2019

 
 
NEWS
 
 
 

Five Amazing Projects That Will Change the Future of Healthcare
CCIL Director Rohit Bhargava's 3D printer was featured by PC Mag as one of the five amazing projects that will change the future of healthcare. Learn more.

 

 
 
 
 
 

Free Fatty Acids Appear to Rewire Cells to Promote Obesity-Related Breast Cancer
Free fatty acids in the blood are linked with higher rates of estrogen-receptor positive breast cancer in obese postmenopausal women, according to a new study led by Food Science and Human Nutrition Professor Zeynep Madak-Erdogan. Learn more.

 
 
 
 
 

Study Finds That Mutations in Noncoding Genes Could Play a Big Role in Regulating Cancer
Professor Kannanganattu Prasanth led a team that found that certain genes that don’t code for proteins could play an important regulatory role in breast cancer. Learn more.

 
UPCOMING EVENTS

April Faculty Seminar Series
Join us for next month's faculty seminar on April 18 from 3:00 to 4:00 p.m. at Beckman Institute (Room 4269) featuring Pablo Perez-Pinera, Assistant Professor of Bioengineering, and Catherine Murphy, Professor of Chemistry. RSVP here.

 
 
 
 

C*STAR Spring Reception and Poster Session
Save April 24, 2019, for the upcoming C*STAR Spring Reception and Poster Session at the Beckman Institute. More details to come.

 
 
 
 

Register for the TiMe Day Symposium
The third annual TiMe Day Symposium on April 26, 2019, will highlight research from the program, include keynote and plenary talks, and culminate with a poster session in which all graduate and undergraduate students are encouraged to present their work. Illinois faculty, staff, and students are welcome to attend this event, and graduate students and undergraduates conducting tissue microenvironment-related research are invited to submit abstracts and present posters. Reserve your spot here

 
 
 
 

Register Now for Cancer Research Advocacy Day
Registration is now open for Cancer Research Advocacy Day. The event is a way to promote interactions between cancer survivors, researchers, and clinicians and honor those who have been impacted by the disease. View the agenda, check out the scheduled speakers, and reserve your spot here.

 
 
 
 

Carl R. Woese Institute for Genomic Biology Seminar Series
Intratumoral Immunotherapy: Occam's Pharmacokinetics
March 26, 2019
12:00 p.m.
Chemical and Life Sciences Building, Charles G. Miller Auditorium (Room B102)

K. Dane Wittrup, PhD
C.P. Dubbs Professor, Chemical and Biological Engineering, MIT

 
 
 

Molecular and Integrative Physiology Seminar
Tumor Microenvironment and Dormancy
March 28, 2019
11:00 a.m.
Charles Miller Auditorium, B102, CLSL

Cyrus Ghajar, PhD
Fred Hutchinson Cancer Research Center

 
CAMPUS FUNDING OPPORTUNITIES

Public Voices Fellowship
Executive Vice President/Vice President for Academic Affairs
Deadline: April 26, 2019 

 
EXTERNAL FUNDING OPPORTUNITIES

ACS Research Grants
The American Cancer Society
Deadline: April 1, 2019

Tina's Wish Rising Star Grants 
Tina Brozman Foundation
Deadline: April 29, 2019

1. Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
2. Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
National Institutes of Health
Deadline: September 27, 2019

1. Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
2. Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
National Institutes of Health
Deadline: September 27, 2019

1. Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
2. Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
3. Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
National Institutes of Health
Deadline: September 27, 2019
 

Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
Department of Health and Human Services
August 3, 2020

FY19 Breast Cancer Research Program
DOD
Deadlines Vary

 
 

If you received an award, published a paper, or have news to share, we want to hear from you.
Send your news items to cancercenter@illinois.edu

Visit the Cancer Center Events Calendar
for upcoming cancer-related activities and events.

Follow us on Twitter at @CancerCenterIL.


cancer.illinois.edu | cancercenter@illinois.edu | @CancerCenterIL